Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review surveying AI-guided drug discovery approaches in ophthalmology with mostly preclinical findings; it raises questions about translational potential rather than reporting clinical evidence or definitive efficacy.
Early-phase, uncontrolled mechanistic work demonstrating proof-of-concept for a novel delivery platform in mouse models, human cells in vitro, and one non-human primate, without efficacy endpoints or clinical outcome data.